Bruno Jas

Siparex XAnge Venture SAS is an Independent Venture Capital firm founded in 1977 by Benjamin Teszner. Siparex XAnge Venture SAS is headquartered in Paris.

Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France.

Limousin Participations SA is a regional private equity investment firm established through the 1997 merger of SRP Limousin-Capital Croissance (founded in 1989) and ENL Développement, created in 1988 by young entrepreneurs. Since 2001 the firm has a strategic alliance with Sofimac Partners, the manager among other investment vehicles of the seed fund Le Lanceur, focused on the neighboring Massif Central region. Limousin Participations is based in Limoges in central France. Shareholders include the Limousin Region, the government-controlled private equity firm CDC Entreprises, regional savings banks, insurance companies including mutually-owned entities, private individuals and entrepreneurs.

Invers SA engages in the provision of sustainable animal feed and fertilization. It offers dog, cat, bird food, and natural fertilizer. The company was founded by Sebastien Crepieux, Stéphanie Cailloux, David Quittard, and Ludovic Tournier in March 2018 and is headquartered in Saint-Beauzire, France.

Lytess SA produces and sells health and beauty cosmetic textile products. It offers Slim Express, a shaping textile with a micro-encapsulated slimming serum; Stop Cellulite, a micro-massaging product for an anti-cellulite treatment and Sculpt & Slim, a corrective and slimming shapewear for immediate and slimming effect. The company was founded in 2003 by Philippe Andrieu and is headquartered in Fondettes, France.

BW Ideol specializes in the designing and installation of foundation solutions for the offshore wind industry. It offers ring-shaped platforms for offshore wind turbines and engineering and installation services. The company was founded by Pierre Coulombeau and Paul de la Guérivière in June 2010 and is headquartered in La Ciotat, France.

Aurora SAS is a French Normandy-based company that specializes in sterilization for medical devices, agribusiness, and space. The company develops an industrial-sized sterilizer that uses plasma obtained from air gas, which is cost-effective and energy-efficient. Jan Laarman and Thomas Parias are the CEO and President, respectively, and co-founders of Aurora.

Axima Centre SA provides highway and street contracting services. The company was founded in 1957 and is headquartered in Villefranche-sur-Saône, France.

Otonomy Aviation SAS designs and develops embedded aeronautical security systems. Its technical features offers both security (intelligent video motion analysis based on a high detection level), and high definition entertainment (video of flight phases screened to passengers in the cabin). The offers its services to the mechanical and industrial engineering industries. The company was founded by Guillaume Daudon and is headquartered in Merignac, France.

Tout Pour L'Eau SA is a French company that specializes in providing equipment and accessories for swimming pools, as well as tools and spare parts for pool equipment. The company is based in Lyon, France. The company offers products for water treatment and filtration. The company was founded in 1956. Sébastien Gauthier has been the CEO of the company since 2021.

AB2 SAS (Private Equity) is a Private Equity firm, a subsidiary of AB2 SAS founded in 1998. AB2 SAS (Private Equity) is headquartered in Paris, France.

Bocamexa SAS is a restaurant specializing in Mexican food. The company was founded on April 7, 2010 and is headquartered in Paris, France.

Capital Croissance SAS (Capital Croissance) is a private equity firm. The firm was founded in 2010 by Eric Neuplanche. The firm headquartered in Paris, France.

Keensight Capital SAS (Keensight) is an independent French venture capital firm which was established in 2001. Formerly known as R Capital Management SAS, a subsidiary of the Rothschild Group, the firm became independent in 2013 and changed their name to Keensight Capital. Keensight is located in Paris and manages venture capital investments, including the FCPR R Capital Technologies for a range of clients including European banks, pension schemes, insurance companies, government-controlled entities, fund of funds, family offices and high-net worth private individuals.

Elaia Partners SAS (Elaia) is an independent French private equity boutique which was founded in 2002. Named after the Greek word for olive tree, the symbol of resilience, longevity and prosperity, Elaia focuses on software technology companies. The firm is headquartered in Paris and manages Elaia Ventures, a French FCPR fund backed by financial institutions, industrial investors and family offices.

ImmunID SAS researches and develops diagnostic tools for monitoring immune cell repertoire. It specializes in combinatorial repertoire analysis. The firm provides tests which translate the complexity of the immune system into clinically meaningful data. The company was founded by Nicolas Pasqual and Sébastien Weisbuch on March 25, 2005 and is headquartered in Grenoble, France.

Quadrille Capital SAS (Quadrille Capital) is an independent private equity firm founded in 2007. The firm is headquartered in Paris, France with an additional office in United States.

Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France.

CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium.

GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France.

Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France.

Cardiawave SA develops non-invasive medical device to treat a heart condition called aortic stenosis. The company was founded by Emmanuel Messas, Benjamin Bertrand, Mickaël Tanter, Mathieu Pernot and Mathias Fink on October 21, 2014 and is headquartered in Paris, France.

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Biomodex SAS develops 3D printed surgical simulators for medical education and patient-specific preoperative planning. It offers simulators for surgical procedures such as bone drilling, soft tissue suturing, medical device implantation, and sizing. The company was founded by Thomas Marchand and Sidarth Radjou on January 22, 2015 and is headquartered in Paris, France.

Institut Gustave Roussy EURL is a cancer research and treatment center that places innovation at the heart of its services. The private company is based in Chevilly-Larue, France, and has subsidiaries in France. The center has strong partnerships at national and international levels to provide high-value care to all its patients. Patients' rights are protected and guaranteed to ensure their autonomy, respect for their individual liberties, and dignity within the hospital.

Axilum Robotics SAS develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures. Its first project is a robot to assist psychiatrists and neurologists for Transcranial Magnetic Stimulation (TMS). The firm's project TMS is a painless, non invasive medical technique that applies high intensity magnetic impulses to cortex areas by placing a coil on the surface of the head. The company was founded by Bernard Bayle, Michel Berg, Michel de Mathelin, Romuald Ginhoux, Benjamin Maurin and Pierre Renaud in April 2011 and is headquartered in Strasbourg, France.

INSERM Transfert Initiative SAS is a venture capital fund that invests in companies located in France. It targets startups from the life sciences and biotechnology sectors, developing new medical practices with a strong intellectual property. It invests between €1 million and €3 million per company during mostly at pre-seed, seed and early-stages.

Crédit Agricole des Savoie Capital SASU (CADS Capital) is a private equity firm headquartered in Annecy-le-Vieux, France. It was founded in 1983 and is a subsidiary of Caisse Régionale de Crédit Agricole Mutuel des Savoie ultimately owned by Crédit Agricole SA.